Understanding Multidrug-Resistant Tuberculosis
Author Information
Author(s): Ellen M Zager, Ruth McNerney
Primary Institution: London School of Hygiene & Tropical Medicine
Hypothesis
Current methods of describing the epidemiology of drug-resistant tuberculosis are inadequate.
Conclusion
The problem of drug-resistant tuberculosis in sub-Saharan Africa is more critical than previously perceived.
Supporting Evidence
- MDR-TB has been reported in all regions of the world.
- Sub-Saharan Africa has some of the highest rates of transmitted MDR-TB.
- Current reporting methods do not reflect the true burden of drug-resistant tuberculosis.
Takeaway
Tuberculosis is a big problem, and some areas thought to have low drug resistance actually have high rates of drug-resistant cases.
Methodology
Re-analysis of global surveillance data on drug-resistant tuberculosis incidence.
Potential Biases
Sampling strategies for previously treated cases varied, affecting representativeness.
Limitations
Data on previously treated cases was not included, leading to potential underestimation of MDR-TB incidence.
Participant Demographics
Data compiled from 97 countries or geographical settings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website